News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Pre-Clinical
enGene, Inc.'s Mucosal Gene Delivery Platform Is Successful In Targeting PD-L1 Expression In The Gut, Demonstrating Effective Treatment Of Colitis And Gvhd In Preclinical Models 4/28/2017
ASKA Pharmaceutical And TesoRx Announce TSX-011 (Oral Testosterone) Proceeding To Human Studies Following Successful PK Study Results 4/27/2017
Novan Presents Preclinical Data From Inflammatory Skin Diseases Program 4/27/2017
Cellectar Biosciences  (CLRB)’s Radiotherapeutic Pdcs Demonstrate An Increased Survival Benefit Using Multiple Doses In Preclinical Studies 4/27/2017
uniQure (QURE) Presents New Preclinical Data On AMT-130 In Huntington’s Disease At CHDI’s 12th Annual Huntington’s Disease Therapeutics Conference 4/26/2017
Theravance Biopharma (TBPH) Release: New Data For VIBATIV (Telavancin) Reported In Several Presentations At ECCMID 2017 4/25/2017
DiFUSION Technologies Announces Breakthrough SMART Biomaterial Platform 4/25/2017
Matinas BioPharma Presents Positive Preclinical Data Of Orally Available DNA Vaccines At The 27th Annual European Congress Of Clinical Microbiology And Infectious Diseases 4/24/2017
PROMETHERA Biosciences S.A./N.V. Presents Preclinical Data On Novel H2Stem Cell Therapy At EASL International Liver Congress 4/21/2017
Bicycle Therapeutics Announces A Candidate Preclinical Milestone In Its Ophthalmology Alliance With ThromboGenics NV (TBGNF) 4/20/2017
ProMetic Life Sci (PFSCF.PK)'s PBI-4050 Shown To Reduce Liver Damage And Fibrosis In High-Fat Diet Induced Obesity And Metabolic Syndrome Mouse Model 4/20/2017
NeuroVive (NVP) Presents Preclinical Findings Of NV556 In NASH Showing Confirmatory Anti-Fibrotic Effects 4/20/2017
Can Scientists Rejuvenate An Aging Brain With Young Blood? Stanford University Study 4/20/2017
Gilead (GILD) To Present Clinical And Preclinical Data On Nonalcoholic Steatohepatitis (NASH) At The International Liver Congress 2017 4/20/2017
Inventiva Announces Presentation Of Preclinical Results On IVA337 In NASH At The International Liver Congress 2017 (EASL) 4/20/2017
Enanta Pharmaceuticals, Inc. Announces New Preclinical Data On Its FXR Agonist EDP-305 For Non-Alcoholic Steatohepatitis (NASH) And Primary Biliary Cholangitis (PBC) At The International Liver Congress 2017 4/19/2017
Synthetic Biologics (SYN) Reports Preclinical Data Demonstrating SYN-005 Provides Protection From Pertussis In Neonatal Animal Study 4/19/2017
BrainStorm Cell Announces Publication of NurOwn Autism Research Study 4/19/2017
Entest Biomedical, Inc.'s Subsidiary, Zander Therapeutics, Inc., Initiates Ex Vivo Studies On Modulating NR2F6 In Canines 4/19/2017
Immuron Announces Positive Results Of IMM-124E In Acute Colitis Research Studies 4/19/2017
City of Hope Researchers Successfully Prevent Graft-Versus-Host Disease While Preserving Strong Graft Versus Leukemia Effects In Preclinical Study 4/18/2017
Protalix (PLX) Announces New Preclinical Results Demonstrating A Positive Effect Of Pegunigalsidase Alfa (PRX-102) On Small-Fiber Neuropathy In Fabry Disease Models Compared To Commercially Available Enzyme Replacement Therapies 4/18/2017
XOMA  (XOMA) Presents Positive Data From PTH1R Monoclonal Antibody Program 4/18/2017
Celsion (CLSN) Reports Preclinical Results Of ThermoDox For The Treatment Of Bladder Cancer Published In The International Journal Of Hyperthermia 4/13/2017
Ocera Therapeutics (OCRX) Announces Presentation Of Data Showing OCR-002 Prevented Progression Of Fibrosis In Preclinical Model Of Non-Alcoholic Fatty Liver Disease (NAFLD) 4/13/2017
Regen BioPharma Sees Success In Its Pre-Clinical Small Molecule Optimization Program For NR2F6 4/12/2017
Xbrane Biopharma Reports Positive In-Vivo Efficacy Data On Spherotide 4/11/2017
Know Bio, LLC Respiratory Has New Name, Novoclem Therapeutics, New Antimicrobial Drug Candidate For Lung, Respiratory Infections 4/11/2017
Recce (RCE) Operational Update 4/10/2017
MyDx (MYDX) Achieves 40,000+ Cannabis Consumer Generated Pre-Clinical Data Points Growing At 100% Year Over Year 4/10/2017
Hutchison China MediTech (Chi-Med) Presented Pre-Clinical Data For Fruquintinib And Sulfatinib At The AACR Annual Meeting 2017 4/7/2017
BlackThorn Therapeutics Announces Results Of Preclinical Study Of BTRX-335140, Demonstrating Therapeutic Potential In Modulating Brain Circuits Commonly Dysregulated In Neurobehavioral Disorders 4/6/2017
Halozyme (HALO) CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data 4/6/2017
Boston Biomedical Presents New Preclinical Data At AACR 2017 Highlighting The Potential Role Of Cancer Stemness Inhibition 4/5/2017
Tolero Pharmaceuticals Presents Preclinical Data On CDK9 Inhibitor Alvocidib And Its Prodrug, TP-1287, At AACR 2017 4/5/2017
Kite Pharma (KITE) Presents Promising Preclinical Data From KITE-585, A Fully Human Anti-BCMA CAR T-Cell Product Candidate At The 2017 AACR Annual Meeting 4/5/2017
XTL Biopharma (XTLB) Unveils Expanded hCDR1 Preclinical Data For The Treatment Of Sjögren’s Syndrome 4/5/2017
Cascadian Therapeutics (ONTY) Highlights Preclinical Program Presentations at the AACR Annual Meeting 2017 4/5/2017
Cyclacel Pharma (CYCC) Presents Identification Of Sensitive Target Indications And Synergistic Drug Combinations For Novel PLK1 Inhibitor CYC140 4/5/2017
Eisai Company (ESALY.PK) Presents Data Of Mechanisms Of Action Relating To Tumor Immune Response Regarding Combination Of Anticancer Agent Lenvatinib With Anti-PD-1 Antibody At AACR 108th Annual Meeting 4/5/2017
Heat Biologics (HTBX) Presents New Preclinical Data From Oncosec Collaboration At The AACR Annual Meeting 4/5/2017
Siamab Presents New Preclinical Data For Its Novel Anti-Stn Antibodies, Antibody-Drug Conjugates, And Anti-Stn Bispecific Antibodies At The AACR Annual Meeting 2017 4/4/2017
H3 Biomedicine Presents New Data From Its RNA Splicing Platform At AACR 4/4/2017
CBT Pharma Presents Data Demonstrating Anti-Tumor Activity Of Its Highly Specific C-MET Inhibitor, Bozitinib (CBT-101), At AACR Annual Meeting 2017 4/4/2017
Intensity Therapeutics, Inc. Reports That INT230-6 Induces Protective T-Cell Immunity In Preclinical Models 4/4/2017
amcure Presents Preclinical Data On Lead Cancer Compound AMC303 At AACR Annual Meeting 4/4/2017
Spectrum Pharma (SPPI) Highlights Preclinical Data Of ROLONTIS (Eflapegrastim) At The AACR Annual Meeting 4/4/2017
Nektar Therapeutics (NKTR) Presents New Preclinical Data For Its Immuno-Oncology Programs At The AACR Annual Meeting 4/4/2017
Benitec (BLT.AX) Release: Key Pre-Clinical Data On Oculopharyngeal Muscular Dystrophy (OPMD) Published In Nature Communications 4/4/2017
Lakewood-Amedex Inc. Advances Novel Bisphosphocin Nu-8 Compound Based On Encouraging Pre-Clinical Results 4/4/2017
Bellicum (BLCM) Announces Late-Breaking Presentation Of Dual-Switch CAR-T / TCR Technology At AACR 4/4/2017
BioDirection Announces Results From Pre-Clinical Study Of Tbit System For Detection Of Traumatic Brain Injury 4/3/2017
Genprex Reports New Pre-Clinical Data Showing Strong Anti-Tumor Effect Of TUSC2 In Combination With PD-1 Checkpoint Blockade In Lung Cancer 4/3/2017
Cyclacel Pharma (CYCC)'s Second-Generation CDK2/9 Inhibitor, CYC065, Elicits Marked Antineoplastic Effects In Lung Cancer By Engaging Anti-Metastatic Pathways 4/3/2017
eFFECTOR Presents Positive Preclinical Data On Lead Product Candidate At AACR 2017 4/3/2017
Sierra Oncology Collaborator ICR Reports Preclinical Synthetic Lethality Data For Chk1 Inhibitor SRA737 At AACR 4/3/2017
Syros Pharma Presents New Preclinical Data At AACR Showing Anti-Tumor Activity Of SY-1365, Its First-In-Class Selective CDK7 Inhibitor, In Multiple Difficult-To-Treat Solid Tumors 4/3/2017
Ensysce Biosciences Inc. Publishes Manuscript Describing The In Vitro Abuse Deterrence Of Oxycodone Prodrug, PF614 4/3/2017
Halozyme (HALO)'s PEGPH20 Increases Immune Response And Effectiveness Of Immunotherapies In Preclinical Cancer Models 4/3/2017
Sutro Biopharma ADC Targeting CD74 Eradicates B-Cell Hematologic Malignancy, Prolongs Survival In Tumor Models 4/3/2017
OncoSec Medical Presents Preclinical Data Demonstrating Improved Systemic Anti-Tumor Response Following Modifications To IL-12 Gene Delivery Therapy At AACR Annual Meeting 4/3/2017
Eleven Bio (EBIO) Presents New Preclinical Data At AACR Supporting The Potential Of The Company’s Locally- And Systematically-Administered Drug Candidates 4/3/2017
Envigo Launches R2G2 Double Knockout Mouse Model 4/3/2017
Peregrine (PPHM) Announces Presentation of Preclinical Study Results Highlighting Potential of PS-Targeting Antibodies to Enhance Anti-Tumor Activity of Adoptive T Cell Transfer Therapy with No Added Off-Target Toxicities 4/3/2017
Sunesis (SNSS) Announces Presentation Of The Ohio State University-Sponsored Preclinical Study Of BTK Inhibitor SNS-062 At AACR Annual Meeting 4/3/2017
TRANSGENE (ENX:TNG) Presents Very Promising New Immunology Data Of Its Next Generation Armed Oncolytic Virus At The AACR Annual Meeting In Washington, DC 3/31/2017
TRANSGENE (ENX:TNG) Presents Very Promising New Immunology Data Of Its Next Generation Armed Oncolytic Virus At The AACR Annual Meeting In Washington, DC 3/30/2017
Kite Pharma (KITE) To Present Two Plenary Presentations From The ZUMA-1 Pivotal Trial Of Axicabtagene Ciloleucel At The 2017 AACR Annual Meeting 3/30/2017
VAXIMM To Present Preclinical Data On Three Novel Oral T-Cell Immunotherapies At AACR Annual Meeting 2017 3/30/2017
Unique Mechanism Of Action Of Verseon (VSN.L)’s Novel Class Of Anticoagulants To Be Presented At American Chemical Society Meeting 3/30/2017
Marina Biotech (MRNA) To Present Data On IT-102 And IT-103 At 2017 AACR Annual Meeting 3/30/2017
Clovis Oncology (CLVS) Announces Data Presentations At AACR Annual Meeting 2017 3/29/2017
PHARNEXT To Present New PXT864 Synergy Data At AD/PDTM 2017, The 13th International Conference On Alzheimer's And Parkinson's Diseases And Related Neurological Disorders 3/29/2017
Sangamo Therapeutics (SGMO) Announces Presentation Of New Data Demonstrating Significant Reduction Of Tau Expression Using Proprietary ZFP Gene Regulation Technology 3/29/2017
Clearlight Diagnostics To Present Data On The Multiplex 3D Imaging Of The Tumor Microenvironment In A Variety Of Preclinical And Clinical Cancer Models 3/29/2017
Cyteir Therapeutics Presents Preclinical Data Validating RAD51-AID As A Novel Target For Cancer Treatment At AACR Annual Meeting 3/28/2017
Tarveda To Present PEN-221 Data In Small Cell Lung Cancer Models At 2017 AACR Annual Meeting 3/28/2017
Cardax Pharmaceuticals Inc. Astaxanthin Compound CDX-085 Stimulates Anti-Aging Gene In Mice 3/28/2017
Euclises Pharmaceuticals To Present Preclinical Efficacy Results At AACR 3/28/2017
Kadmon Presents Preclinical Data Supporting The Therapeutic Potential Of ROCK Inhibition In Pulmonary Fibrosis 3/28/2017
Eleven Bio (EBIO) To Present New Preclinical Data At AACR Annual Meeting 2017 3/27/2017
Alkermes (ALKS) To Present Preclinical Data On ALKS 4230 At AACR Annual Meeting 3/27/2017
Cincinnati Children's Hospital Medical Center Release: MicroRNA Treatment Restores Nerve Insulation, Limb Function In Mice With MS 3/27/2017
Marina Biotech (MRNA) To Present Data On Vascular Resistance And Cancer At Endocrine Society Annual Meeting On April 1 3/27/2017
Old Blood Can Be Made Young Again, University of Ulm Scientists Reveal 3/24/2017
Synlogic To Present At 2017 American College Of Medical Genetics And Genomics Annual Meeting 3/23/2017
Kineta RLR Agonist Demonstrates Tumor Regression And An Adaptive Immune Response In Colon Carcinoma Model 3/23/2017
Intellia’s CEO Has Cambridge-Based Company Moving Forward on Positive in vivo Data 3/22/2017
Cytokinetics (CYTK) Announces Preclinical Data For CK-2127107 Presented At MDA Scientific Conference 3/22/2017
University of Liverpool Release: Results Of Mouse Studies Deeply Affected By The Way The Animals Are Handled 3/22/2017
Cue BioPharma Announces Selection Of Lead Candidate Cue-101 Targeting Human Papillomavirus (HPV)-Associated Cancers 3/22/2017
ERYtech Pharma Presents New Preclinical Anti-Tumor Data On Erymethionase At AACR 2017 3/21/2017
OWC Pharmaceutical Research Corp. Releases Promising Preliminary Results From Efficacy Tests Of Its Topical Cream 3/21/2017
Everon Biosciences Introduces Physiological Frailty Index As A Measure Of Biological Age In Mice, Enhancing The Development Of Healthspan-Extending Pharmaceuticals 3/21/2017
GeoVax Labs Inc. (GOVX.OB) Reports Promising Results For Zika Vaccine 3/20/2017
American Academy Of Pain Medicine Release: Stem Cell Transplantation Produces Remarkable Therapeutic Effects On Neuropathic Pain In Animal Models 3/17/2017
ObsEva (OBSV) To Present Pharmacology Results Demonstrating OBE022 Exerts A Synergistic Effect In Combination With Standard Of Care In Animal Model For Preterm Labor 3/17/2017
Cincinnati Children's Hospital Medical Center Release: Study Identifies Molecular Clues For Age-Related Intestinal Issues 3/15/2017
twoXAR Announces Preclinical Proof-of-Concept Data On Novel Liver Cancer Candidate 3/14/2017
Experimental Biology And Medicine Release: Reducing Heart Failure In Pulmonary Hypertension 3/14/2017
Taconic Biosciences Announces Expansion Of Key Immunodeficient Animal Model Production 3/10/2017
Siamab Announces Publication Of New Preclinical Data In The Journal mAbs Describing Its Novel Monoclonal Antibody Approach To Targeting The Tumor-Associated Carbohydrate Antigen STn 3/8/2017
Regenacy Pharma Demonstrates Reversal Of Chemotherapy-Induced Peripheral Neuropathy With HDAC6 Inhibitor Ricolinostat In Preclinical Model 3/8/2017
Matinas BioPharma Announces Positive Preclinical Efficacy Results Of MAT2501 In An In Vitro Model Of Mycobacterium Abscessus Infection 3/8/2017
Abbott (ABT) Release: New Study Results May Lead To A New Standard Of Care For In Vitro Fertilization Treatment 3/8/2017
ERYtech Pharma To Present Preclinical Results Supporting Immunotherapy Potential Of ERYMMUNE Platform At Two Upcoming Medical Meetings 3/7/2017
Cyclacel Pharma (CYCC)’s CDK Inhibitor CYC065 Causes Anaphase Catastrophe, A Novel Cancer-Specific Mechanism Of Action, In Research Published In JNCI 3/7/2017
Attune Announces Pre-Clinical Data For ATN-249, An Oral Plasma Kallikrein Inhibitor For The Treatment Of HAE At AAAAI 3/6/2017
Artificial Embryo Shows Early Potential For Medical Therapies, Not Babies, Cambridge University Study Reveals 3/3/2017
Batu Biologics Publishes Mechanistic Preclinical Data For ValloVax 3/3/2017
This Is Big News For Diabetics And Biotech Investors 3/2/2017
GlycoMimetics, Inc. (GLYC) To Present New Preclinical Data In Multiple Myeloma At AACR Annual Meeting 2017 3/2/2017
Cynata Advances Development Of Cymerus MSCs For The Treatment Of Asthma 3/2/2017
Tonix Pharma (TNXP) Announces Demonstrated Vaccine Activity In First-Ever Synthesized Chimeric Horsepox Virus 3/2/2017
University of Pennsylvania Release: Highly Prevalent Gene Variants In Minority Populations Cause Kidney Disease 3/2/2017
Acuitas Therapeutics Release: Findings Published In Nature Communications Show That Mrna-LNP Encoding A Neutralizing Antibody Protect Humanized Mice From HIV Challenge 3/2/2017
Luxcel Biosciences And HD Biosciences Co., Ltd Enter Collaboration Agreement For Mitochondria Toxicity & Metabolism Assays For Preclinical Drug Safety Evaluation 3/1/2017
Onxeo Appoints Seasoned Executives To Accelerate Preclinical And Clinical Development 3/1/2017
NovAliX Turns To High-Resolution Cryo-Transmission Electron Microscopy For Pre-Clinical Drug Discovery Research 3/1/2017
New Preclinical Data Show Can-Fite BioPharma (CFBI)'s Namodenoson (CF102) Prevents Progression Of Liver Fibrosis 2/28/2017
Sangamo Therapeutics (SGMO) Receives Rare Pediatric Disease Designation From FDA For SB-318 In Vivo Genome Editing Therapeutic For MPS I 2/27/2017
Mologen (MOLGF.PK): First Combination Data Of TLR9 Agonists Enandim With Checkpoint Inhibitor In Preclinical Tumor Models 2/27/2017
Inovio Pharma (INO)’s SynCon WT1 Cancer Antigen Breaks Tolerance, Highlights Potential For Universal Cancer Immunotherapy 2/27/2017
Corbus (CRBP) Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation In Alveolar Macrophages From Cystic Fibrosis Patients 2/24/2017
MabSpace Biosciences To Present Preclinical Data On Second Generation PD-L1 Antibody With pH-Dependent Antigen Binding Property At Upcoming Inaugural ASCO-SITC Clinical Immuno-Oncology Symposium 2/23/2017
Atreca Presents New Preclinical Findings For Novel Cancer Immunotherapy Platform At Molecular Medicine Tri-Conference 2017 2/22/2017
Kineta Release: KCP-400 Relieves Chronic Pain And Demonstrates Disease Modifying Effects 2/22/2017
ToolGen Highlights Study Results Demonstrating Utility Of AAV-Compatible Cas9 System In Vivo Genome Editing 2/22/2017
CohBar Announces Positive Results From Preclinical NASH Study Of Its Lead Drug Candidates 2/21/2017
CEL-SCI (CVM) Scientist Presents New Findings For Rheumatoid Arthritis Treatment Vaccine At Conference 2/21/2017
Arvinas Presents New Preclinical Data On Oral Androgen Receptor PROTAC At ASCO 2017 Genitourinary Cancers Symposium 2/20/2017
Protagonist (PTGX) Presents Data On Oral Peptide Drug Candidates At European Crohn's And Colitis Organization (ECCO) Congress 2/17/2017
Windtree Therapeutics (WINT)' Aerosolized KL4 Surfactant Reduces Lung Inflammation And Improves Survival In A High-Pathogen Avian Influenza Preclinical Study 2/16/2017
Gilead (GILD) Announces Findings From New Preclinical Study Evaluating Novel Class Of HIV Capsid Inhibitors 2/14/2017
Marinus Pharma (MRNS) Release: Ganaxolone Reduces Seizures And Improves Behaviors in Angelman Syndrome Preclinical Model 2/14/2017
MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 With Halozyme (HALO) PEGPH20 2/13/2017
IGC Launches Phytocannabinoid Development Committee To Secure Preclinical Initiatives For IGC-501, IGC-502 And IGC-504 2/13/2017
Viking Therapeutics (VKTX) Announces Initial Results From In Vivo Proof-Of-Concept Study Of VK2809 In Glycogen Storage Disease Ia (GSD Ia) 2/9/2017
Spotlight Innovation Engages Top-Tier Contract Research Organization To Conduct Preclinical Studies Of STL-182 2/8/2017
Selecta (SELB) Presents Preclinical Data Regarding SVP-Enabled Peanut Allergy Therapeutic Vaccine And Celiac Disease Treatment 2/6/2017
Boston Children's Hospital Release: Gene Therapy Restores Hearing In Deaf Mice… Down To A Whisper 2/6/2017
Catalyst Biosciences Announces Positive Preclinical Data Of Subcutaneously Dosed Coagulation Factors VIIa And IX At EAHAD Annual Congress 2/1/2017
SignalRX Pharmaceuticals Announces Breakthrough Results On Novel Anti-Cancer Dual PI3K-BRD4 Inhibition Paradigm In PNAS Publication 2/1/2017
Noveome Publishes Data Demonstrating Anti-Inflammatory Activity Of ST266 In A Preclinical Model Of Optic Neuritis 1/31/2017
Mologen (MOLGF.PK) Release: Combination Data Of TLR9 Agonist Lefitolimod With Checkpoint Inhibitors In Preclinical Tumor Models 1/23/2017
Infinity Pharma (INFI) Release: Company Presents Preclinical Data And Phase 1 Clinical Data On IPI-549 At PI3K Keystone Symposia Conference 1/20/2017
NeuroVive (NVP) Release: Pharma Presents Positive Preclinical Data In Hepatocellular Cancer At HCC Summit 1/19/2017
Gladstone Institute Release: Scientists Discover Drug That Increases "Good" Fat Mass And Function 1/18/2017
Recce (RCE) Release: Pharma’s Lead Compound Reduces Illness In Mice Infected By Resistant E. Coli Bacteria 1/18/2017
WinSanTor Release: Researchers Publish Preclinical Data On Reversing Peripheral Neuropathy 1/18/2017
Washington University School of Medicine Release: Persistent Infection Keeps Immune Memory Sharp, Leading To Long-Term Protection 1/17/2017
Protein Sciences Corporation Release: Pharma Zika Vaccine Shows Good Results in Preclinical Testing 1/12/2017
Regenacy Pharma Release: Pharma's HDAC1,2 Inhibitors Demonstrate Single-Agent And Synergistic Activity With Azacitidine (Vidaza) In Preclinical Models Of Acute Myeloid Leukemia 1/11/2017
PetLife Pharma Release: Company Reports The First Of Three Preclinical Studies In Their pre-INAD Process For Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions Across Multiple Dosing Levels 1/10/2017
Profectus BioSciences, Inc. Bivalent Vaccine Protects Animals From Infection And Death After Exposure To Chikungunya Or Zika Virus 1/9/2017
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Statistically Significant Efficacy In A Highly Translational Preclinical Model Of Chronic Osteoarthritis Pain 1/9/2017
AdAlta Pty Ltd. Announces Positive Pre-clinical Data Showing Lead Drug Candidate Has Broad Fibrosis Treatment Potential 1/9/2017
XTL Biopharma (XTLB)' Preclinical Studies of hCDR1 Demonstrate Therapeutic Potental In the Treatment of Sjögren's Syndrome 1/5/2017
Cascadian Therapeutics (ONTY) Announces 2017 Outlook And Recent Drug Portfolio Progress 1/5/2017
Catabasis (CATB) Research On CAT-5571, A Novel Activator Of Autophagy And Potential Oral Treatment For Cystic Fibrosis, Published In Journal Of Medicinal Chemistry 1/5/2017
Top Harvard Scientist Retracts Diabetes Breakthrough Paper 1/4/2017
Catabasis (CATB) Release: Positive Preclinical Research On The Edasalonexent (CAT-1004) Program, A Potential Disease-Modifying Therapy For Duchenne Muscular Dystrophy, Published In JCI Insight 1/4/2017
Ionis Pharma (IONS) And AstraZeneca PLC (AZN) Advance First Generation 2.5 LICA Drug Into Preclinical Development To Treat Cardiovascular Disease 12/20/2016
Benitec (BLT.AX) Releases Pivotal Data In An In Vivo Hepatitis B Model 12/20/2016
New Preclinical Data Show Can-Fite BioPharma (CFBI)'s Namodenoson (CF102) Inhibits Liver Fibrosis -- Supports Potential Efficacy In Treatment Of NASH 12/16/2016
Newly Published Data Reinforce Growing Body Of Evidence Supporting Cidara (CDTX)’ Lead Antifungal CD101 12/14/2016
Organovo (ONVO) Presents First Preclinical Data On 3D Bioprinted Human Liver Tissues At TERMIS-Americas Meeting 12/13/2016
Moleculin Biotech (MBRX) Presents Preclinical Data Of Novel Inhibitor Of Glycolysis At 28th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 12/13/2016
Discussion On Advaxis (ADXS)’ ADXS-NEO, ADXS-HOT Programs Held During The International Congress On Immunotherapies In Cancer 12/12/2016
Syros Pharma Presents New Preclinical Data Demonstrating Significant Anti-Proliferative Effects Of Its First-in-Class Selective RARa Agonist In Genomically Defined Subsets Of Breast Cancer 12/12/2016
NantKwest Announces Enhanced High-Affinity Activated Natural Killer (Hank) Cell Therapy In Preclinical Studies Of HER2 Positive Breast Cancer At Presentation At The San Antonio Breast Cancer Symposium 12/12/2016
ABIVAX Reports New Preclinical Data Supporting ABX464 As HIV Functional Cure And Novel Treatment For Inflammatory Diseases At HIV DART Meeting 12/9/2016
Matinas BioPharma Receives Contract Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Study MAT2501 For The Treatment Of NTM-Infection In Pre-Clinical Models Of CF 12/8/2016
ContraVir's Cyclophilin Inhibitor CRV431 Potently Inhibits Essential Pathway In Hepatitis B 12/8/2016
BerGenBio AS Release: New Breast Cancer Research Highlights BGB324 In Overcoming Immunotherapy Resistance 12/8/2016
Spectrum Pharma (SPPI) Highlights Promising Preclinical Data Evaluating Poziotinib In Lung Cancer At The 17th IASLC World Conference On Lung Cancer 12/8/2016
Advaxis (ADXS) To Present Data At Imvacs-Immunization And Vaccine Summit On Use Of Detoxified Listeriolysin O (dtLLO) As An Effective Adjuvant In Vaccine Formulations 12/7/2016
Further Research Confirms That Verseon (VSN.L)’s New Class Of Anticoagulants Reduce Bleeding Risk Compared To NOACs By Preserving Platelet Function 12/7/2016
Arvinas Collaborators Present Data On BET PROTAC Degraders At 2016 American Society of Hematology Annual Meeting 12/6/2016
Nordic Nanovector: Betalutin In Combination With Rituximab Demonstrates Synergistic Anti-Tumour Effect In Preclinical Non-Hodgkin Lymphoma Model 12/6/2016
ImmunoGen (IMGN) Release: Preclinical Data On IMGN632, A Novel CD123-Targeting ADC, Presented At American Society of Hematology Annual Meeting 12/6/2016
Bellicum (BLCM) Announces GoCAR-T and GoTCR Preclinical Presentations at the American Society of Hematology 2016 Annual Meeting 12/6/2016
Acetylon Presents Preclinical Data Demonstrating The Utility Of Selective HDAC1,2 Inhibition By ACY-957 To Induce Gamma Globin (HBG) Protein Expression For The Treatment Of Sickle Cell Disease And Beta-Thalassemia 12/5/2016
Shire (SHPG) Reports On Four Decades Of Real-World Safety Experience With FEIBA [Anti-Inhibitor Coagulant Complex] 12/5/2016
Bellicum (BLCM) Announces GoCAR-T And GoTCR Preclinical Presentations At The American Society of Hematology 2016 Annual Meeting 12/5/2016
Imara Presents Results For IMR-687, A PDE9 Inhibitor, In Sickle Cell Disease At American Society of Hematology 12/5/2016
CTI BioPharma Presents Nonclinical Pharmacology Study Demonstrating Pacritinib Has Distinct Profile Amongst JAK Inhibitors At European Organization for Research and Treatment of Cancer-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium 12/2/2016
Surface Oncology CD47 Program Demonstrates Promising Anti-Tumor Activity In Hematological Disease Models 12/2/2016
Kura Oncology Presents Preclinical Data On KO-947 And Menin-MLL Inhibitor Program At The EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 12/1/2016
A1M Pharma Has Successfully Conducted Preclinical Toxicology/Safety Studies Within Preeclampsia 12/1/2016
VAXIMM Presents Preclinical Data On Three Novel Oral T-Cell Cancer Immunotherapies At EORTC-NCI-AACR Symposium 12/1/2016
Axial Biotherapeutics Announces The Groundbreaking Discovery Of A Biological Link Between The Gut Microbiome And Parkinson’s Disease Published In Cell 12/1/2016
Pharmazz Advances Its Product Pipeline For The Treatment Of Stroke, Strengthens Patent Portfolio And Presents Hemorrhagic Shock Data At The AHA 11/30/2016
X4 Pharma Announces New Data For Lead Candidate X4P-001 In Renal Cell Carcinoma At EORTC-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium 11/30/2016
Cyteir Therapeutics Presents Preclinical Data On Use Of DNA Repair Modulators For Lymphoid Malignancies At American Society of Hematology Annual Meeting 11/29/2016
Ignyta (RXDX) To Debut Preclinical Data On RXDX-106 At The 2016 EORTC-NCI-AACR Annual Meeting 11/29/2016
PhaseRx (PZRX) Receives Orphan Drug Designation From FDA For PRX-OTC For The Treatment Of Ornithine Transcarbamylase Deficiency 11/28/2016
Portola (PTLA) Announces Andexxa™ (Andexanet Alfa), Betrixaban And Cerdulatinib Data To Be Presented At 2016 American Society of Hematology Annual Meeting And Exposition 11/28/2016
AiCuris Announces U.S. NIH Support Of Preclinical Study With AIC649 Against Chronic Hepatitis B 11/23/2016
Baxter International (BAX) Presented Exploratory Research On The Removal Of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy 11/22/2016